Human extracellular matrices can be edited in their composition using the CRISPR/Cas9 system, leading to materials exhibiting tailored regenerative capacities.
1d
Randomized 87 patients to date in Phase 2b CHASE trial of KPI-012 in Persistent Corneal Epithelial Defect (PCED) -- -- ...
The following is a summary of "Controversial Role Of Cd151 In Different Solid Tumors: Promoter Or Suppressor?,” published in ...
Scientists have unveiled a revolutionary method for mass-producing high-quality human mitochondria, potentially transforming ...
In vitro tests indicate that cannabidiol can stimulate the biomineralization of teeth even under inflammatory conditions, ...
Gastric cancer (GC) is a leading cause of cancer-related deaths worldwide, with more than one million new diagnoses annually.
Aged individuals and astronauts experience bone loss despite rigorous physical activity. Bone mechanoresponse is in-part ...
Good afternoon and welcome to the BioCardia year-end 2024 financial results and business update conference call. (Operator Instructions) A webcast replay of the call will be available approximately ...
MELVILLE, N.Y., March 27, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BioRestorative”, "BRTX” or the "Company”) ...
Secondary endpoints in the MINDFuL trial include the CDR-SB, E-Cog, ADL and Neuropsychiatric Inventory (NPI) instruments, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback